Successful treatment of idiopathic febrile panniculitis (Weber-Christian disease) with thalidomide in a patient having failed multiple other medical therapies

Journal of Clinical Rheumatology

Volumn 8, Issue 5, 2002, Pages 256-259

  Barthel, H Richard ^a   Charrier, Ulrich ^a   Kramer, Martin ^a   Loch, Christoph ^a  

^a NONE   (Germany)

Author keywords

Lupus profundus; Pannicultis; Thalidomide; Weber Christian disease

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DOXYCYCLINE; HYDROXYCHLOROQUINE; METHOTREXATE; THALIDOMIDE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; DRUG EFFICACY; FEVER; HUMAN; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; WEBER CHRISTIAN PANNICULITIS; WEIGHT GAIN;

EID: 0036790227     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200210000-00005     Document Type: Article

References (40)

1. Pfeifer V. Über einen Fall von herdweiser Atrophie des subcutanen Fettgewebes [About a case of multifocal atrophy of the subcutaneous fat tissue] [German]. Dtsch Arch Klin Med 1892; 50:438.
2. a. Amelung W, Puntmann E: [Clinical aspects and therapy of the so-called contergan-polyneuropathy] [German]. Nervenarzt 1966;37: 189-99.
3. Weber EP. A case of relapsing nonsuppurative nodular panniculitis. Br J Dermatol 1925;37: 301.
4. Christian HA. Relapsing febrile nodular non-suppurative panniculitis. Arch Intern Med 1928;41:338.
5. Martens PB, Moder KG, Ahmed I. Lupus panniculitis: clinical perspectives from a case series. J Rheumatol 1999;26:68-72.
6. White JW Jr, Winkelmann RK. Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol 1998;39:56-62.
7. Dahl PR, Su WP, Cullimore KC, et al. Pancreatic panniculitis. J Am Acad Dermatol 1995;33: 413-7.
8. Loche F, Tremeau-Martinage C, Laplanche G, et al. Panniculitis revealing qualitative alpha 1 antitrypsine deficiency (MS variant). Eur J Dermatol 1999;9:565-7.
9. O'Riordan K, Blei A, Rao MS, et al. Alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation. Transplantation 1997;63:480-2.
10. Furey NL, Golden RS, Potts SR. Treatment of alpha-1-antitrypsin deficiency, massive edema, and panniculitis with alpha-1 protease inhibitor. Ann Intern Med 1996;125:699.
11. Conti JA, Kramer N, Rosenstein ED. Cytophagic panniculitis and lupus panniculitis versus Weber-Christian disease. Am J Med 1989;87: 3-4.
12. Crotty CP, Winkelmann RK. Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure, and terminal hemorrhagic diathesis. J Am Acad Dermatol 1981;4:181-94.
13. Panush RS, Yonker RA, Dlesk A, et al. Weber-Christian disease: analysis of 15 cases and review of the literature. Medicine 1985;64:181-91.
14. th edition. New York: McGraw Hill, 1999. p. 1275-128.
15. Hannuksela M. Erythema nodosum migrans. Acta Derm Venereol 1973;53:313.
16. Steininger H, Missmahl M. Weber-Christian panniculitis with systemic cytophagic histiocytosis. Klin Wochenschr 1988;66:365-72.
17. Viravan S, Wisuthsarewong W, Manonukul J, et al. Successful treatment of cytophagic histiocytic panniculitis by cyclosporin A: a case report. Asian Pac J Allergy Immunol 1997;15: 161-6.
18. Nakane S, Kawabe Y, Eguchi K, et al. A case of cytophagic histiocytic panniculitis: successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A. Clin Rheumatol 1997;16:417-21.
19. Ostrov BE, Athreya BH, Eichenfield AH, et al. Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A. Semin Arthritis Rheum 1996;25:404-13.
20. Ito M, Ohira H, Miyata M, et al. Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment. Intern Med 1999;38:296-301.
21. Grossberg E, Scherschun L, Fivenson DP. Lupus profundus: not a benign disease. Lupus 2001;10:514-6.
22. Diaz-Jouanen E, DeHoratius RJ, Alarcon-Segovia D, et al. Systemic lupus erythematosus presenting as panniculitis (lupus profundus). Ann Intern Med 1975;82:376-9.
23. Szyszymar B, Gwiezdzinski Z. [Treatment of recurrent panniculits febrilis nonsuppurativa with methotrexate] [Polish]. Przegl Dermatol 1974;61:623-7.
24. Hotta T, Wakamatsu Y, Matsumura N, et al. Azathioprine-induced remission in Weber-Christian disease. South Med J 1981; 74:234-7.
25. Sorensen RU, Abramowsky C, Stern RC. Corticosteroid-sparing effect of hydroxychloroquine in a patient with early-onset Weber-Christian syndrome. J Am Acad Dermatol 1990;23:1172-4.
26. Meyers WK. Chloroquine diphosphate therapy in Weber Christian Syndrome. Ann Int Med 1959;51:791-5.
27. Usuki K, Kitamura K, Urabe A, et al. Successful treatment of Weber-Christian disease by cyclosporin A. Am J Med 1988;85:276-8.
28. Iwasaki T, Hamano T, Ogata A, et al. Successful treatment of a patient with febrile, lobular panniculitis (Weber-Christian disease) with oral cyclosporin A: implications for pathogenesis and therapy. Intern Med 1999;38:612-4.
29. Entzian P, Barth J, Monig H, et al. Treatment of Weber-Christian panniculitis with cyclosporme A. Rheumatol Int 1987;7:181.
30. Kirch W, Duhrsen U, Hoensch H, et al. Cyclophosphamide-induced remission in Weber-Christian panniculitis. Rheumatol Int 1985;5: 239-40.
31. Martin RJ, Michals EL, Voth MR. Cyclophosphamide-induced remission in Weber-Christian disease: case report. Mil Med 1977;142: 158-60.
32. Enk AH, Knop J. Treatment of relapsing idiopathic nodular panniculitis (Pfeifer-Weber-Christian disease) with mycophenolate mofetil. J Am Acad Dermatol 1998;39:508-9.
33. Proenca NG, Muller H. [Weber-Christian panniculitis treated with sulfone. Report of 2 cases] Portuguese. AMB Rev Assoc Med Bras 1981;27:309-12.
34. Burrows NP, Walport MJ, Hammond AH, et al. Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide. Br J Dermatol 1991;125:62-7.
35. Ordi-Ros J, Cortes F, Cucurull E, et al. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 2000;27:1429-33.
36. Moreiara AL, Sampaio EP, Zmuidzinas A, et al. Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation. J Exp Med 1991;177: 1675-80.
37. McHugh SM, Rifkin IR, Deighton J, et al. The immunosuppressive drug thalidomide induces T-helper cell type 2 (TH-2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995;99:160-7.
38. Adlard JW. Thalidomide in the treatment of cancer. Anticancer Drugs 2000;11:787-91.
39. Eravelly J, Waters MF. Thalidomide in Weber-Christian disease [letter]. Lancet. 1977;29; 1(8005):251.
40. Oconisky S, Verroust J, Bastuji S, et al. Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients. Arch Dermatol 1994;130:66-9.